Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Inidascamine - Recognify Life Sciences

Next Previous
Drug Profile

Inidascamine - Recognify Life Sciences

Alternative Names: FSV7 007; Inidascamine-Recognify Life Sciences; RL-007

Latest Information Update: 22 Aug 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Recognify Life Sciences
  • Class Antipsychotics; Nootropics
  • Mechanism of Action Cholinergic receptor modulators; GABA B receptor modulators; NMDA receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Cognition disorders

Most Recent Events

  • 30 Jul 2025 Atai Life Sciences completes a phase IIb trial in Cognition disorders (Treatment-experienced) in the US Poland, Czech Republic, Bulgaria (PO) (NCT05686239)
  • 25 Jul 2025 Updated efficacy and adverse events data from a phase IIb trial in Cognition disorders released by Recognify Life Sciences
  • 31 Dec 2023 Recognify Life Sciences has patent protection for Inidascamine worldwide

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top